Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females

NCT00818155 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: desvenlafaxine succinate SR
OTHER: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer